Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rat hepatitis E virus infection has multiphasic viral replication kinetics <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

Reducing Supply Chain Dependencies for Viral Genomic Surveillance: Get by with a Little HELP from Commercial Enzymes already in your Lab Freezer.

Wellcome open research·2026
Same author

Machine learning framework for cost effective deep mutational scanning through targeted substitution profiling.

BMC bioinformatics·2026
Same author

Convergent enrichment of Gammaproteobacteria along Aedes aegypti development across different breeding sites.

Animal microbiome·2026
Same author

The honey bee triad: a comprehensive catalogue of phages in the Apis mellifera gut microbiome.

Nature communications·2026
Same author

Coding-complete genome sequence of a divergent black queen cell virus strain identified from honeybees (<i>Apis mellifera</i>) in Romania.

Microbiology resource announcements·2026
Same journal

RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases.

PLoS pathogens·2026
Same journal

How Saprolegniales became successful parasites.

PLoS pathogens·2026
Same journal

Anti-malarial contact dependent blocking of transmission of Plasmodium vivax by Anopheles darlingi mosquito vector.

PLoS pathogens·2026
Same journal

A single Citrobacter rodentium infection in Pink1 knockout and wild-type mice leads to regional blood-brain-barrier perturbation and limited microglial activation without dopamine neuron axon terminal loss.

PLoS pathogens·2026
Same journal

Correction: Structural basis for substrate recognition and inhibition of thioredoxin glutathione reductase from Schistosoma japonicum: Implications for antiparasitic development.

PLoS pathogens·2026
Same journal

Balancing under constraint: Structural insights into norovirus evolution and antigenic innovation.

PLoS pathogens·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.5K

A robust human norovirus replication model in zebrafish larvae.

Jana Van Dycke1, Annelii Ny2, Nádia Conceição-Neto3

  • 1KU Leuven-Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium.

Plos Pathogens
|September 20, 2019
PubMed
Summary
This summary is machine-generated.

Human noroviruses (HuNoVs) cause significant foodborne illness. Zebrafish larvae now offer a robust model for studying HuNoV replication and developing new antiviral treatments.

More Related Videos

Author Spotlight: Establishing Germ-Free Zebrafish for Microbiota-Host Relationship Studies
05:38

Author Spotlight: Establishing Germ-Free Zebrafish for Microbiota-Host Relationship Studies

Published on: April 12, 2024

2.2K
Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
06:28

Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection

Published on: November 27, 2014

10.6K

Related Experiment Videos

Last Updated: Jan 19, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
09:07

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

10.5K
Author Spotlight: Establishing Germ-Free Zebrafish for Microbiota-Host Relationship Studies
05:38

Author Spotlight: Establishing Germ-Free Zebrafish for Microbiota-Host Relationship Studies

Published on: April 12, 2024

2.2K
Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
06:28

Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection

Published on: November 27, 2014

10.6K

Area of Science:

  • Virology
  • Infectious Diseases
  • Animal Models

Background:

  • Human noroviruses (HuNoVs) are a leading cause of foodborne illness globally.
  • The absence of effective small animal models impedes norovirus research and therapeutic development.

Purpose of the Study:

  • To establish and validate a novel small animal model for human norovirus replication.
  • To assess the utility of this model for antiviral drug screening.

Main Methods:

  • Infection of zebrafish (Danio rerio) larvae with human norovirus (HuNoV) GI and GII strains.
  • Monitoring viral replication titers over time (up to 6 days post-infection).
  • Serial passaging of the virus between larvae and assessment of viral tropism in host tissues.

Main Results:

  • High-titer replication of HuNoV GI and GII was observed in zebrafish larvae, peaking at day 2 post-infection.
  • The GII.4 strain demonstrated successful serial passaging between larvae, indicating sustained infectivity.
  • HuNoV was detected in hematopoietic and intestinal cells, suggesting dual tissue tropism.
  • Antiviral treatment significantly reduced viral replication (>2 log10), confirming model suitability for drug studies.

Conclusions:

  • Zebrafish larvae provide a simple, robust, and effective model for human norovirus replication.
  • This model system will accelerate the understanding of norovirus pathogenesis.
  • The validated model is well-suited for high-throughput screening of antiviral compounds against noroviruses.